Sonnet Announces Release of Corporate Update Video
PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs ...
Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.
Pankaj was a respected leader and visionary throughout his ten years at Sonnet. His unwavering belief in Sonnet’s technology and dedication to providing much needed treatment options to patients has ...
The Scientist13y
Blood Protein from Rice
The highly sought-after plasma protein, human serum albumin (HSA), can now be produced at high yield and purity in rice, according to a report published today (October 31) in Proceedings of the ...
Sonnet BioTherapeutics’ (SONN) “Buy” Rating Reiterated at Chardan Capital
Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Chardan Capital in a research note issued on Friday,Benzinga reports. They presently have a ...
CNN4y
Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a ...